{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04541",
    "Peptide Name": "Kn2-5 ( BmKn2-T5, BmKn2 analog, synthetic AMPs, XXA, UCLL1c)",
    "Source": "amino acid deletion, amino acid substitution, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "FIARLLSKIF",
    "Sequence Length": 10,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Anti-Gram+"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 3,
    "Boman Index": -0.35,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "70%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Sequence analysis: APD analysis reveals that this sequence is similar (76.92%) toparent peptide BmKn2I: 20%, L=F: 20%, others: 10%.Activity: active against E. coli AB94012 (MIC 100 ug/ml), S. aureus AB94004 (MIC 12.5 ug/ml).Antiviral: showed dose-dependent inhibitory activity against Enterovirus 71 (EV71) in the Early Stages, DENV, Zika virus (ZIKV), and HSV-1 (Xia et al., 2024). \nparticularly in the attachment or entry stage",
    "Author": "Cao L, Dai C, Li Z, Fan Z, Song Y, Wu Y, Cao Z, Li W.2012",
    "Reference": "PLoS One. 2012;7(7):e40135. doi: 10.1371/journal.pone.0040135.PubMed",
    "Title": "Antibacterial activity and mechanism of a scorpion venom peptide derivative in vitro and in vivo."
  },
  "3D Structure": []
}